Unknown

Dataset Information

0

Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis.


ABSTRACT: microRNAs (miRNAs) are noncoding RNAs that regulate gene expression in post-transcriptional fashion, and emerging studies support their importance in a multitude of physiological and pathological processes. Here, we describe the regulation and function of miR-29 in Duchenne muscular dystrophy (DMD) and its potential use as therapeutic target. Our results demonstrate that miR-29 expression is downregulated in dystrophic muscles of mdx mice, a model of DMD. Restoration of its expression by intramuscular and intravenous injection improved dystrophy pathology by both promoting regeneration and inhibiting fibrogenesis. Mechanistic studies revealed that loss of miR-29 in muscle precursor cells (myoblasts) promotes their transdifferentiation into myofibroblasts through targeting extracellular molecules including collagens and microfibrillar-associated protein 5 (Mfap5). We further demonstrated that miR-29 is under negative regulation by transforming growth factor-? (TGF-?) signaling. Together, these results not only identify TGF-?-miR-29 as a novel regulatory axis during myoblasts conversion into myofibroblasts which constitutes a novel contributing route to muscle fibrogenesis of DMD but also implicate miR-29 replacement therapy as a promising treatment approach for DMD.

SUBMITTER: Wang L 

PROVIDER: S-EPMC3369280 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis.

Wang Lijun L   Zhou Liang L   Jiang Peiyong P   Lu Leina L   Chen Xiaona X   Lan Huiyao H   Guttridge Denis C DC   Sun Hao H   Wang Huating H  

Molecular therapy : the journal of the American Society of Gene Therapy 20120320 6


microRNAs (miRNAs) are noncoding RNAs that regulate gene expression in post-transcriptional fashion, and emerging studies support their importance in a multitude of physiological and pathological processes. Here, we describe the regulation and function of miR-29 in Duchenne muscular dystrophy (DMD) and its potential use as therapeutic target. Our results demonstrate that miR-29 expression is downregulated in dystrophic muscles of mdx mice, a model of DMD. Restoration of its expression by intramu  ...[more]

Similar Datasets

| S-EPMC3698551 | biostudies-literature
| S-EPMC3236595 | biostudies-literature
| S-EPMC5341382 | biostudies-literature
| S-EPMC5643396 | biostudies-literature
| S-EPMC9087951 | biostudies-literature
| S-EPMC3306299 | biostudies-literature
| S-EPMC3498803 | biostudies-other
| S-EPMC3846897 | biostudies-literature
| S-EPMC5840545 | biostudies-literature
| S-EPMC3858279 | biostudies-literature